Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Comparing interval breast cancer rates in Norway and North Carolina: results and challenges.

Hofvind S, Yankaskas BC, Bulliard JL, Klabunde CN, Fracheboud J.

J Med Screen. 2009;16(3):131-9. doi: 10.1258/jms.2009.009012.

PMID:
19805754
3.
4.

Interval breast cancer: is it a different type of breast cancer?

Raja MA, Hubbard A, Salman AR.

Breast. 2001 Apr;10(2):100-8.

PMID:
14965568
5.

Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.

Hofvind S, Bjurstam N, Sørum R, Bjørndal H, Thoresen S, Skaane P.

J Med Screen. 2006;13(4):192-6.

PMID:
17217608
6.

Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.

Bordás P, Jonsson H, Nyström L, Lenner P.

J Med Screen. 2009;16(1):39-45. doi: 10.1258/jms.2009.008098.

PMID:
19349530
7.

Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden.

Vutuc C, Waldhoer T, Haidinger G.

Eur J Cancer Prev. 2006 Aug;15(4):343-6.

PMID:
16835504
8.

Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts.

Bucchi L, Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C; Emilia-Romagna Breast Screening Programme.

J Med Screen. 2008;15(1):30-5. doi: 10.1258/jms.2008.007016.

PMID:
18416953
9.

Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway.

Porojnicu AC, Lagunova Z, Robsahm TE, Berg JP, Dahlback A, Moan J.

Breast Cancer Res Treat. 2007 May;102(3):323-8. Epub 2006 Sep 21.

PMID:
17028983
10.

[Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].

Molinié F, Billon-Delacour S, Allioux C, Blais S, Bercelli P, Lombrail P.

Rev Epidemiol Sante Publique. 2008 Feb;56(1):41-9. doi: 10.1016/j.respe.2008.01.001. Epub 2008 Mar 4. French.

PMID:
18295424
11.

[The effectiveness of population-based breast cancer screening programme].

Szynglarewicz B, Matkowski R, Kasprzak P, Kotowska J, Forgacz J, Pudełko M, Kornafel J.

Pol Merkur Lekarski. 2009 Feb;26(152):117-20. Polish.

PMID:
19388515
12.

Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.

Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, Aalen OO, Tretli S.

J Med Screen. 2008;15(2):83-90. doi: 10.1258/jms.2008.007071.

PMID:
18573776
13.

Interval cancers in the Dutch breast cancer screening programme.

Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, van Ineveld BM, Broeders MJ, de Bruyn AE, van der Maas PJ.

Br J Cancer. 1999 Nov;81(5):912-7.

14.

Estimation of sojourn time in chronic disease screening without data on interval cases.

Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW.

Biometrics. 2000 Mar;56(1):167-72.

PMID:
10783792
15.

[Evaluation of the national epidemiological program of breast cancer screening in the Grand Duchy of Luxembourg, 1999-2002].

Scharpantgen A, Lux C, Wagnon MC, Shannoun F, Schank JM, Back C, Brochmann C, Hansen-Koenig D.

Bull Soc Sci Med Grand Duche Luxemb. 2004;(1):33-9. French.

PMID:
15544001
16.

Overuse of mammography during the first round of an organized breast cancer screening programme.

Chamot E, Charvet A, Perneger TV.

J Eval Clin Pract. 2009 Aug;15(4):620-5. doi: 10.1111/j.1365-2753.2008.01062.x. Epub 2009 Jun 10.

PMID:
19522725
17.

Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?

Hoff SR, Klepp O, Hofvind S.

J Med Screen. 2012 Dec;19(4):177-83. doi: 10.1258/jms.2013.012090.

PMID:
23486698
18.

Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance.

Gram IT, Lund E.

J Med Screen. 2008;15(1):44-5. doi: 10.1258/jms.2008.007014.

PMID:
18416955
19.

Tumour size at detection according to different measures of mammographic breast density.

Nickson C, Kavanagh AM.

J Med Screen. 2009;16(3):140-6. doi: 10.1258/jms.2009.009054.

PMID:
19805755
20.

Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg.

Kellen E, Putte GV, Van Steen A, Cloes E, Lousbergh D, Buntinx F, Van Limbergen E.

Acta Clin Belg. 2008 May-Jun;63(3):179-84.

PMID:
18714848

Supplemental Content

Support Center